64028-90-6Relevant academic research and scientific papers
HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF
-
Paragraph 00170, (2015/12/30)
Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, or pharmaceutically acceptable salts thereof, compositions thereof, and methods of their use. The condition or disorder mediated by HDAC comprises a neurodegenerative pathology. Accordingly, also provided is a method of treating a neurodegenerative pathology mediated by HDAC in a subject in need of such a treatment, comprising administering to the subject a therapeutically effective amount of at least one compound, or pharmaceutically acceptable salt thereof, described herein.
Inter-and intramolecular annulation strategies to a cyclopentanone building block containing an all-carbon quaternary stereogenic center
Penrose, Stephen D.,Stott, Andrew J.,Breccia, Perla,Haughan, Alan F.,Bürli, Roland W.,Jarvis, Rebecca E.,Dominguez, Celia
supporting information, p. 1401 - 1404 (2015/03/30)
Synthesis of (S)-2-methyl-3-fluorophenyl cyclopentanone methyl ester (1S)-1 has been achieved by both inter-and intramolecular alkylation reactions on multigram scale, using chiral pool reagents. The intramolecular variant is a novel example of a chiral bis-electrophile reacting with a carbon nucleophile to form an enantiomerically pure all-carbon quaternary center.
HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS
-
Paragraph 00149, (2014/10/15)
Provided are certain histone deacetylase (HDAC) inhibitors of Formula (I), compositions thereof, and methods of their use.
HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF
-
Paragraph 00144, (2014/10/15)
Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, compositions thereof, and methods of their use.
